531210 — Colinz Laboratories Income Statement
0.000.00%
Last trade - 00:00- IN₹143.08m
- IN₹70.79m
- IN₹70.30m
- 79
- 42
- 64
- 70
Annual income statement for Colinz Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 76 | 61.6 | 69.7 | 71.5 | 70.3 |
| Cost of Revenue | |||||
| Gross Profit | 48.6 | 39.8 | 46.8 | 48.6 | 47.2 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 75 | 60.2 | 65.9 | 66.5 | 66.1 |
| Operating Profit | 1.08 | 1.41 | 3.85 | 5.04 | 4.21 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1.76 | 2.45 | 4.8 | 6 | 6.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.3 | 2.08 | 3.39 | 4.57 | 4.87 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1.3 | 2.08 | 3.39 | 4.57 | 4.87 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.3 | 2.08 | 3.39 | 4.57 | 4.87 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.368 | 0.454 | 0.74 | 1.89 | 1.93 |